SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. 4 月22, 2020. 了解武漢肺炎病毒進入寄主細胞的機制 ...
確定! 回上一頁